IGF2 mRNA binding protein p62/IMP2-2 in hepatocellular carcinoma: antiapoptotic action is independent of IGF2/PI3K signaling

Insulin-like growth factor II mRNA-binding protein 3 expression predicts unfavorable prognosis in patients with neuroblastoma

(2011) Szu-Ta Chen et al.   CANCER SCIENCE

RNA-binding Protein Insulin-like Growth Factor mRNA-binding Protein 3 (IMP-3) Promotes Cell Survival via Insulin-like Growth Factor II Signaling after Ionizing Radiation

(2011) Baisong Liao et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The distribution of IGF2 and IMP3 in osteosarcoma and its relationship with angiogenesis

(2011) Peng Chen et al.   JOURNAL OF MOLECULAR HISTOLOGY

One-Step Preservation of Phosphoproteins and Tissue Morphology at Room Temperature for Diagnostic and Research Specimens

(2011) Claudius Mueller et al.   PLoS One

Human Fatty Liver Disease: Old Questions and New Insights

(2011) J. C. Cohen et al.   SCIENCE

Insulin-like growth factor II mRNA binding protein 3 (IMP3) is overexpressed in prostate cancer and correlates with higher Gleason scores

(2010) Kristian Ikenberg et al.   BMC CANCER

Identification of an autoantibody panel to separate lung cancer from smokers and nonsmokers

(2010) William N Rom et al.   BMC CANCER

IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage

(2010) Victoria Tovar et al.   JOURNAL OF HEPATOLOGY

Overexpression of the IGF2-mRNA binding protein p62 in transgenic mice induces a steatotic phenotype

(2010) Elisabeth Tybl et al.   JOURNAL OF HEPATOLOGY

The role of signaling pathways in the development and treatment of hepatocellular carcinoma

(2010) S Whittaker et al.   ONCOGENE

Tumor-Suppressive Lipoxygenases Inhibit the Expression of c-mycmRNA Coding Region Determinant-Binding Protein/Insulin-Like Growth Factor II mRNA-Binding Protein 1 in Human Prostate Carcinoma PC-3 Cells

(2009) Yuki KAWAKAMI et al.   BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY

A Lymphotoxin-Driven Pathway to Hepatocellular Carcinoma

(2009) Johannes Haybaeck et al.   CANCER CELL

Overactivation of the MEK/ERK Pathway in Liver Tumor Cells Confers Resistance to TGF- -Induced Cell Death through Impairing Up-regulation of the NADPH Oxidase NOX4

(2009) L. Caja et al.   CANCER RESEARCH

Insulin-Like Growth Factor 2 and the Insulin Receptor, But Not Insulin, Regulate Fetal Hepatic Glycogen Synthesis

(2009) Li Liang et al.   ENDOCRINOLOGY

Genomic and expression profiling of adrenocortical carcinoma: application to diagnosis, prognosis and treatment

(2009) Kimberly J Bussey et al.   Future Oncology

Loss of imprinting and marked gene elevation are 2 forms of aberrant IGF2 expression in colorectal cancer

(2009) Yu-Wei Cheng et al.   INTERNATIONAL JOURNAL OF CANCER

IGF2 mRNA-binding protein 2: biological function and putative role in type 2 diabetes

(2009) Jan Christiansen et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

IGF2 is Highly Expressed in Pediatric Undifferentiated Sarcomas and Reveals Two Distinct Cytoplasmic Trafficking Patterns

(2009) Gino R. Somers et al.   PEDIATRIC AND DEVELOPMENTAL PATHOLOGY

Effects of lactational exposure to benzo[α]pyrene (B[α]P) on postnatal neurodevelopment, neuronal receptor gene expression and behaviour in mice

(2009) Jaouad Bouayed et al.   TOXICOLOGY

Down-regulation of extracellular signal-regulated kinase 1/2 activity in P-glycoprotein-mediated multidrug resistant hepatocellular carcinoma cells

(2009) Feng Yan et al.   WORLD JOURNAL OF GASTROENTEROLOGY

RNA-binding protein insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma

(2008) Yung-Ming Jeng et al.   HEPATOLOGY

Hepatitis B Virus-inducedhFGL2Transcription Is Dependent on c-Ets-2 and MAPK Signal Pathway

(2008) Meifang Han et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The Effect of Doxorubicin on MEK-ERK Signaling Predicts Its Efficacy in HCC

(2008) Jennifer Choi et al.   JOURNAL OF SURGICAL RESEARCH

Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection

(2007) Klaus Juergen Schmitz et al.   JOURNAL OF HEPATOLOGY